Key result
A single dose of sotalol increased individual alpha coefficients for QT correction compared to placebo, indicating placebo-derived formulas may not be valid on-drug.
Why the study?
Does a single dose of sotalol alter the individual alpha coefficients for QT correction compared to placebo in healthy subjects?
Does a single dose of sotalol alter the individual alpha coefficients for QT correction compared to placebo in healthy subjects?
Answers are grounded in this paper and cite their sources.
The individual correction formula calculated from the placebo condition cannot always be used for QT correction on a drug, as the drug itself may alter the QT-RR relationship.
The authors aim to highlight the pitfalls of different validated methods used for the assessment of drugs' effect on QT duration. Digital 12-lead Holter electrocardiograms were recorded at baseline and after a single dose of sotalol in 39 healthy subjects (age = 27.4 +/- 8.0 years). Using both time- and rate-based approaches, the authors obtained averaged QRS-T complexes every minute ("time bins") and at different RR intervals ("rate bins"). Time bins were corrected for heart rate using a subject-specific approach. The individual alpha coefficients increased from placebo (0.309 +/- 0.052) to sotalol (0.454 +/- 0.136), P < .0001. When the placebo individual alpha coefficients were applied to correct the QT interval on sotalol, the changes were >5 ms smaller than those obtained using the ON drug alpha coefficients. The "rate"-averaging process leads to a complete loss of the time course of drug effect. In conclusion, the individual correction formula calculated from the placebo condition cannot always be used for QT correction on the drug.
No takes yet. Share an insight, caveat, or question.
Extramiana et al. (2007) studied Healthy subjects (n=39). Sotalol vs. Placebo was evaluated on Individual alpha coefficients for QT correction (p=<.0001). A single dose of sotalol increased individual alpha coefficients for QT correction compared to placebo, indicating placebo-derived formulas may not be valid on-drug.
Synapse has enriched 10 related papers. Consider them for comparative context: